{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:52:50Z","timestamp":1790362370236,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02198-0","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:04:59Z","timestamp":1784527499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Von Willebrand, factor VIII, and D-dimer levels as predictors of risk and clinical outcomes in acute myeloid leukemia"],"prefix":"10.1007","volume":"26","author":[{"given":"Hanaa Ali","family":"EL-Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa H.","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Awad","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Alghandour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Denewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balvinder","family":"Saarsalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Azzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"2198_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A, Cancer statistics. 2024. CA: a cancer journal for clinicians 2024;74(1).","DOI":"10.3322\/caac.21820"},{"issue":"12","key":"2198_CR2","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/cncr.33458","volume":"127","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Ravandi F, Kadia TM, et al. De novo acute myeloid leukemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Cancer. 2021;127(12):2049\u201361.","journal-title":"Cancer"},{"issue":"3","key":"2198_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(3):502\u201326. https:\/\/doi.org\/10.1002\/ajh.26822. [published Online First: Epub Date]|.","journal-title":"Am J Hematol"},{"issue":"1","key":"2198_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.21608\/amj.2022.212635","volume":"51","author":"AE-ME Shaheen","year":"2022","unstructured":"Shaheen AE-ME, Mohammed Mowafy N, Abo-Nar AE-R, El-Rauf A, ASSESSMENT, OF VON WILLEBRAND FACTOR AND SOLUBLE FIBRIN MONOMER COMPLEX IN LEUKEMIC PATIENTS. Al-Azhar Med J. 2022;51(1):455\u201362.","journal-title":"Al-Azhar Med J"},{"key":"2198_CR5","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/S0049-3848(20)30398-4","volume":"191","author":"NA Horowitz","year":"2020","unstructured":"Horowitz NA, Brenner B. Thrombosis in hematological malignancies: mechanisms and implications. Thromb Res. 2020;191:S58\u201362.","journal-title":"Thromb Res"},{"issue":"20","key":"2198_CR6","doi-asserted-by":"publisher","first-page":"17771","DOI":"10.1007\/s00432-023-05475-7","volume":"149","author":"HA El-Sayed","year":"2023","unstructured":"El-Sayed HA, Othman M, Azzam H, et al. Assessing the risk of venous thromboembolism in patients with haematological cancers using three prediction models. J Cancer Res Clin Oncol. 2023;149(20):17771\u201380.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1\u20132","key":"2198_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10428190009053534","volume":"39","author":"P Porcu","year":"2000","unstructured":"Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma. 2000;39(1\u20132):1\u201318.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2198_CR8","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3109\/10428194.2014.953148","volume":"56","author":"U Rozovski","year":"2014","unstructured":"Rozovski U, Ohanian M, Ravandi F, et al. Incidence of and risk factors for acute myeloid leukemia involvement of the central nervous system. Leuk Lymphoma. 2014;56(5):1392.","journal-title":"Leuk Lymphoma"},{"key":"2198_CR9","doi-asserted-by":"publisher","first-page":"1865189","DOI":"10.1155\/2022\/1865189","volume":"2022","author":"M Liu","year":"2022","unstructured":"Liu M, Yang Q, Zhang L. Analysis of the Influence of Serum MMP-2 and vWF Levels on the Predictive Value of Risk Grade and Prognosis of Patients with Acute Myeloid Leukemia. Contrast Media Mol Imaging. 2022;2022:1865189. https:\/\/doi.org\/10.1155\/2022\/1865189. published Online First: Epub Date.","journal-title":"Contrast Media Mol Imaging"},{"key":"2198_CR10","unstructured":"Scoring systems for diagnosis of acute venous thromboembolism. Seminars in thrombosis and hemostasis. Thieme Medical; 2017."},{"issue":"14","key":"2198_CR11","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1182\/blood-2016-02-701094","volume":"128","author":"EJ Libourel","year":"2016","unstructured":"Libourel EJ, Klerk CPW, van Norden Y, et al. Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia. Blood. 2016;128(14):1854\u201361. https:\/\/doi.org\/10.1182\/blood-2016-02-701094. [published Online First: Epub Date]|.","journal-title":"Blood"},{"issue":"3","key":"2198_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jth.15611","volume":"20","author":"GE Walker","year":"2022","unstructured":"Walker GE, Merlin S, Zanolini D, et al. Factor VIII as a potential player in cancer pathophysiology. J Thromb haemostasis: JTH. 2022;20(3):648\u201360. : 10.1111\/jth.15611[published Online First: Epub Date]|.","journal-title":"J Thromb haemostasis: JTH"},{"key":"2198_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.thromres.2020.09","volume":"196","author":"VE Castell\u00f3n Rubio","year":"2020","unstructured":"Castell\u00f3n Rubio VE, Segura PP, Mu\u00f1oz A, Farr\u00e9 AL, Ruiz LC, Lorente JA. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score. Thromb Res. 2020;196:349\u201354. https:\/\/doi.org\/10.1016\/j.thromres.2020.09. .021[published Online First: Epub Date]|.","journal-title":"Thromb Res"},{"issue":"2","key":"2198_CR14","first-page":"68","volume":"16","author":"S Khalilian","year":"2024","unstructured":"Khalilian S, Mohajer Z, Ghafouri-Fard S. Factor VIII as a novel biomarker for diagnosis, prognosis, and therapy prediction in human cancer and other disorders. Avicenna J Med Biotechnol. 2024;16(2):68.","journal-title":"Avicenna J Med Biotechnol"},{"issue":"4","key":"2198_CR15","first-page":"1035","volume":"109","author":"M Franchini","year":"2023","unstructured":"Franchini M, Focosi D, Pezzo MP, Mannucci PM. How we manage a high D-dimer. Haematologica. 2023;109(4):1035.","journal-title":"Haematologica"},{"issue":"1","key":"2198_CR16","doi-asserted-by":"publisher","first-page":"e000162","DOI":"10.1136\/lupus-2016-000162","volume":"3","author":"JC Nossent","year":"2016","unstructured":"Nossent JC, Raymond WD, Eilertsen G. Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation. Lupus Sci Med. 2016;3(1):e000162. : 10.1136\/lupus-2016-000162[published Online First: Epub Date]|.","journal-title":"Lupus Sci Med"},{"issue":"12","key":"2198_CR17","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377. https:\/\/doi.org\/10.1182\/blood.2022016867. [published Online First: Epub Date]|.","journal-title":"Blood"},{"issue":"4","key":"2198_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias French-American\u2010British (FAB) co\u2010operative group. Br J Haematol. 1976;33(4):451\u201358.","journal-title":"Br J Haematol"},{"key":"2198_CR19","volume-title":"statistics for windows, version 25.0. Armonk","author":"S IBMCorp Ibm","year":"2017","unstructured":"IBMCorp Ibm S. statistics for windows, version 25.0. Armonk. NY: IBM Corp; 2017."},{"issue":"1","key":"2198_CR20","first-page":"65","volume":"22","author":"S Raso","year":"2024","unstructured":"Raso S, Lucchesi A, Sardo M, et al. Global hemostasis assays in acute myeloid leukemia: results of an observational prospective study. Blood Transfus = Trasfusione del sangue. 2024;22(1):65\u201374. : 10.2450\/BloodTransfus.575[published Online First: Epub Date]|.","journal-title":"Blood Transfus = Trasfusione del sangue"},{"issue":"7","key":"2198_CR21","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","volume":"23","author":"D Farge","year":"2022","unstructured":"Farge D, Frere C, Connors JM, et al. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 2022;23(7):e334\u201347. (22)00160-7[published Online First: Epub Date]|.","journal-title":"Lancet Oncol"},{"issue":"2","key":"2198_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jth.12075","volume":"11","author":"A Falanga","year":"2013","unstructured":"Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb haemostasis: JTH. 2013;11(2):223\u201333. : 10.1111\/jth.12075[published Online First: Epub Date]|.","journal-title":"J Thromb haemostasis: JTH"},{"issue":"1\u20132","key":"2198_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/10428199909145951","volume":"36","author":"K Chojnowski","year":"1999","unstructured":"Chojnowski K, Wawrzyniak E, Treli\u0144ski J, Niewiarowska J, Cierniewski C. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment. Leuk Lymphoma. 1999;36(1\u20132):77\u201384. : 10.3109\/10428199909145951[published Online First: Epub Date]|.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2198_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/CCO.0000000000000402","volume":"29","author":"MI Del Principe","year":"2017","unstructured":"Del Principe MI, Del Principe D, Venditti A. Thrombosis in adult patients with acute leukemia. Curr Opin Oncol. 2017;29(6):448\u201354. : 10.1097\/cco.0000000000000402[published Online First: Epub Date]|.","journal-title":"Curr Opin Oncol"},{"issue":"29","key":"2198_CR25","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1200\/jco.2009.22.8197","volume":"27","author":"A Falanga","year":"2009","unstructured":"Falanga A, Marchetti M. Venous thromboembolism in the hematologic malignancies. J Clin oncology: official J Am Soc Clin Oncol. 2009;27(29):4848\u201357. https:\/\/doi.org\/10.1200\/jco.2009.22.8197. [published Online First: Epub Date]|.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"2","key":"2198_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1538-7836.2010.04126","volume":"9","author":"W Saber","year":"2011","unstructured":"Saber W, Moua T, Williams EC, et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb haemostasis: JTH. 2011;9(2):312\u20139. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04126. x[published Online First: Epub Date]|.","journal-title":"J Thromb haemostasis: JTH"},{"issue":"2","key":"2198_CR27","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00520-021-06339","volume":"30","author":"C McKeown","year":"2022","unstructured":"McKeown C, Ricciuti A, Agha M, et al. A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy. Supportive care in cancer. official J Multinational Association Supportive Care Cancer. 2022;30(2):1673\u201379. https:\/\/doi.org\/10.1007\/s00520-021-06339-. x[published Online First: Epub Date]|.","journal-title":"official J Multinational Association Supportive Care Cancer"},{"issue":"Suppl 2","key":"2198_CR28","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/s0049-3848(10)70024-4","volume":"125","author":"T Wun","year":"2010","unstructured":"Wun T, White RH. Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma. Thromb Res. 2010;125(Suppl 2):S96\u2013102. https:\/\/doi.org\/10.1016\/s0049-3848(10)70024-4. [published Online First: Epub Date]|.","journal-title":"Thromb Res"},{"issue":"6","key":"2198_CR29","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1365-2141.2005.05529","volume":"129","author":"A Cortelezzi","year":"2005","unstructured":"Cortelezzi A, Moia M, Falanga A, et al. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br J Haematol. 2005;129(6):811\u20137. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05529. x[published Online First: Epub Date]|.","journal-title":"Br J Haematol"},{"issue":"1","key":"2198_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12959-024-00607-6","volume":"22","author":"M Mitrovic","year":"2024","unstructured":"Mitrovic M, Pantic N, Bukumiric Z, et al. Venous thromboembolism in patients with acute myeloid leukemia: development of a predictive model. Thromb J. 2024;22(1):37. https:\/\/doi.org\/10.1186\/s12959-024-00607-6. [published Online First: Epub Date]|.","journal-title":"Thromb J"},{"issue":"7","key":"2198_CR31","doi-asserted-by":"publisher","first-page":"e6136","DOI":"10.1097\/MD.0000000000006136","volume":"96","author":"C Liu","year":"2017","unstructured":"Liu C, Zhao L, Zhao J, Xu Q, Song Y, Wang H. Decreased ADAMTS-13 level is related to inflammation factors and risk stratification of acute lymphoblastic leukemia patients. Medicine. 2017;96(7):e6136.","journal-title":"Medicine"},{"issue":"5","key":"2198_CR32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/1078155213508439","volume":"20","author":"AA Hagag","year":"2014","unstructured":"Hagag AA, Abdel-Lateef AE, Aly R. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia. J Oncol Pharm Pract. 2014;20(5):356\u201361.","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"2198_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clml.2018.07.294","volume":"19","author":"M Gavriatopoulou","year":"2019","unstructured":"Gavriatopoulou M, Terpos E, Ntanasis-Stathopoulos I, et al. Elevated vWF antigen serum levels are associated with poor prognosis, and decreased circulating ADAMTS-13 antigen levels are associated with increased IgM levels and features of WM but not increased vWF levels in patients with symptomatic WM. Clin Lymphoma Myeloma Leuk. 2019;19(1):23\u20138.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"2198_CR34","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1016\/j.clml.2019.12.016","volume":"20","author":"R Castelli","year":"2020","unstructured":"Castelli R, Bergamaschini L, Teatini T, et al. Does outcome\/survival of patients with myelodysplastic syndromes should be predicted by reduced levels of ADAMTS-13? Results from a pilot study. Clin Lymphoma Myeloma Leuk. 2020;20(8):e461\u201367.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"2198_CR35","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1200\/JCO.2000.18.3.600","volume":"18","author":"K Blackwell","year":"2000","unstructured":"Blackwell K, Haroon Z, Broadwater G, et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol. 2000;18(3):600\u201300.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2198_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/sj.bjc.6600069","volume":"86","author":"LY Dirix","year":"2002","unstructured":"Dirix LY, Salgado R, Weytjens R, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 2002;86(3):389\u201395.","journal-title":"Br J Cancer"},{"issue":"8","key":"2198_CR37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/jjco\/hye075","volume":"31","author":"M Oya","year":"2001","unstructured":"Oya M, Akiyama Y, Okuyama T, Ishikawa H. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol. 2001;31(8):388\u201394.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"2198_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/cncr.20336","volume":"101","author":"K Blackwell","year":"2004","unstructured":"Blackwell K, Hur\u1e83itz H, Lieb\u00e9rman G, et al. Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer: Interdisciplinary Int J Am Cancer Soc. 2004;101(1):77\u201382.","journal-title":"Cancer: Interdisciplinary Int J Am Cancer Soc"},{"issue":"7","key":"2198_CR39","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.clon.2007.04.002","volume":"19","author":"G Altiay","year":"2007","unstructured":"Altiay G, Ciftci A, Demir M, et al. High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol. 2007;19(7):494\u201398.","journal-title":"Clin Oncol"},{"issue":"6","key":"2198_CR40","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/thx.52.6.563","volume":"52","author":"O Taguchi","year":"1997","unstructured":"Taguchi O, Gabazza EC, Yasui H, Kobayashi T, Yoshida M, Kobayashi H. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax. 1997;52(6):563\u201365.","journal-title":"Thorax"},{"key":"2198_CR41","doi-asserted-by":"crossref","unstructured":"Hoke M, Dieckmann K, Koppensteiner R, Schillinger M, Marosi C, Mlekusch W. Prognostic value of plasma d-dimer levels in patients with glioblastoma multiforme-Results from a pilot study. Wiener klinische Wochenschrift 2011;123.","DOI":"10.1007\/s00508-011-1556-9"},{"issue":"8","key":"2198_CR42","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3324\/haematol.2011.054718","volume":"97","author":"C Ay","year":"2012","unstructured":"Ay C, Dunkler D, Pirker R, et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97(8):1158\u201364. https:\/\/doi.org\/10.3324\/haematol.2011.054718. [published Online First: Epub Date]|.","journal-title":"Haematologica"},{"issue":"2","key":"2198_CR43","first-page":"391","volume":"18","author":"M Inanc","year":"2013","unstructured":"Inanc M, Er O, Karaca H, et al. D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer. J buon. 2013;18(2):391\u201397.","journal-title":"J buon"},{"issue":"6","key":"2198_CR44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/030089161109700611","volume":"97","author":"B Komurcuoglu","year":"2011","unstructured":"Komurcuoglu B, Ulusoy S, Gayaf M, Guler A, Ozden E. Prognostic value of plasma D-dimer levels in lung carcinoma. Tumori J. 2011;97(6):743\u201348.","journal-title":"Tumori J"},{"issue":"2","key":"2198_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.lungcan.2006.03.015","volume":"53","author":"D Antoniou","year":"2006","unstructured":"Antoniou D, Pavlakou G, Stathopoulos GP, et al. Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer. 2006;53(2):205\u201310.","journal-title":"Lung Cancer"},{"key":"2198_CR46","doi-asserted-by":"publisher","first-page":"117727192412907","DOI":"10.1177\/11772719241290704","volume":"19","author":"L Alkhoder","year":"2024","unstructured":"Alkhoder L, Salamoon M, Saifo M, Alwassouf S. D-dimer as a Predictive Biomarker of Response to Chemotherapy in Patients With Metastatic Breast Cancer. Biomark Insights. 2024;19:11772719241290704. 10.1177\/11772719241290704[published Online First: Epub Date]|.","journal-title":"Biomark Insights"},{"issue":"10","key":"2198_CR47","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","volume":"22","author":"GT Gerotziafas","year":"2017","unstructured":"Gerotziafas GT, Taher A, Abdel-Razeq H, et al. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study. Oncologist. 2017;22(10):1222\u201331. https:\/\/doi.org\/10.1634\/theoncologist.2016-0414. [published Online First: Epub Date]|.","journal-title":"Oncologist"},{"issue":"7","key":"2198_CR48","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/s2352-3026(18","volume":"5","author":"I Pabinger","year":"2018","unstructured":"Pabinger I, van Es N, Heinze G, et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. Lancet Haematol. 2018;5(7):e289\u201398. https:\/\/doi.org\/10.1016\/s2352-3026(18. )30063-2[published Online First: Epub Date]|.","journal-title":"Lancet Haematol"},{"issue":"4","key":"2198_CR49","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00277-022-04770-6","volume":"101","author":"F Martella","year":"2022","unstructured":"Martella F, Cerrano M, Di Cuonzo D, et al. Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study. Ann Hematol. 2022;101(4):855\u201367. https:\/\/doi.org\/10.1007\/s00277-022-04770-6. [published Online First: Epub Date]|.","journal-title":"Ann Hematol"},{"issue":"12","key":"2198_CR50","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.clml.2015.07.637","volume":"15","author":"EJ Lee","year":"2015","unstructured":"Lee EJ, Smith BD, Merrey JW, et al. Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey. Clin lymphoma myeloma Leuk. 2015;15(12):766\u201370. [published Online First: Epub Date]|.","journal-title":"Clin lymphoma myeloma Leuk"},{"issue":"5","key":"2198_CR51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4251\/wjgo.v11.i5.424","volume":"11","author":"H Takaya","year":"2019","unstructured":"Takaya H, Namisaki T, Shimozato N, et al. ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma. World J Gastrointest Oncol. 2019;11(5):424.","journal-title":"World J Gastrointest Oncol"},{"issue":"45","key":"2198_CR52","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.3748\/wjg.v26.i45.7232","volume":"26","author":"H Takaya","year":"2020","unstructured":"Takaya H, Namisaki T, Moriya K, et al. Association between ADAMTS13 activity\u2013VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma. World J Gastroenterol. 2020;26(45):7232.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2198_CR53","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5009\/gnl17115","volume":"14","author":"C Schwarz","year":"2018","unstructured":"Schwarz C, Fitschek F, Mittlb\u00f6ck M, et al. von Willebrand factor antigen predicts outcomes in patients after liver resection of hepatocellular carcinoma. Gut Liver. 2018;14(2):218.","journal-title":"Gut Liver"},{"issue":"2","key":"2198_CR54","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/cam4.71","volume":"2","author":"Y Liu","year":"2013","unstructured":"Liu Y, Starr MD, Bulusu A, et al. Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab. Cancer Med. 2013;2(2):234\u201342.","journal-title":"Cancer Med"},{"key":"2198_CR55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.blre.2018.06.002","volume":"33","author":"N Kekre","year":"2019","unstructured":"Kekre N, Connors JM. Venous thromboembolism incidence in hematologic malignancies. Blood Rev. 2019;33:24\u201332.","journal-title":"Blood Rev"},{"issue":"17","key":"2198_CR56","first-page":"3911","volume":"113","author":"GH Ku","year":"2009","unstructured":"Ku GH, White RH, Chew HK, Harvey DJ, Zhou H, Wun T. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood J Am Soc Hematol. 2009;113(17):3911\u201317.","journal-title":"Blood J Am Soc Hematol"},{"issue":"9","key":"2198_CR57","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1111\/j.1538-7836.2005.01467.x","volume":"3","author":"V De Stefano","year":"2005","unstructured":"De Stefano V, Sora F, Rossi E, et al. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost. 2005;3(9):1985\u201392.","journal-title":"J Thromb Haemost"},{"issue":"01","key":"2198_CR58","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1160\/TH13-12-1020","volume":"113","author":"Y-G Lee","year":"2015","unstructured":"Lee Y-G, Kim I, Kwon J-h, et al. Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia. Thromb Haemost. 2015;113(01):201\u201308.","journal-title":"Thromb Haemost"},{"issue":"2","key":"2198_CR59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jth.12075","volume":"11","author":"A Falanga","year":"2013","unstructured":"Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost. 2013;11(2):223\u201333.","journal-title":"J Thromb Haemost"},{"issue":"1\u20132","key":"2198_CR60","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/10428199909145951","volume":"36","author":"K Chojnowski","year":"1999","unstructured":"Chojnowski K, Wawfuyniak E, Treilinski J, Niewiarowska J, Cierniewski C. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment. Leuk Lymphoma. 1999;36(1\u20132):77\u201384.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2198_CR61","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/CCO.0000000000000402","volume":"29","author":"MI Del Principe","year":"2017","unstructured":"Del Principe MI, Del Principe D, Venditti A. Thrombosis in adult patients with acute leukemia. Curr Opin Oncol. 2017;29(6):448\u201354.","journal-title":"Curr Opin Oncol"},{"issue":"29","key":"2198_CR62","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1200\/JCO.2009.22.8197","volume":"27","author":"A Falanga","year":"2009","unstructured":"Falanga A, Marchetti M. Venous thromboembolism in the hematologic malignancies. J Clin Oncol. 2009;27(29):4848\u201357.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2198_CR63","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/DCR.0b013e318197e2b2","volume":"52","author":"MT Stender","year":"2009","unstructured":"Stender MT, Fr\u00f8kj\u00e6r JB, Larsen TB, Lundbye-Christensen S, Thorlacius-Ussing O. Preoperative plasma D-dimer is a predictor of postoperative deep venous thrombosis in colorectal cancer patients: a clinical, prospective cohort study with one-year follow-up. Dis colon rectum. 2009;52(3):446\u201351.","journal-title":"Dis colon rectum"},{"issue":"24","key":"2198_CR64","first-page":"5377","volume":"116","author":"C Ay","year":"2010","unstructured":"Ay C, Dunkler D, Marosi C, et al. Prediction of venous thromboembolism in cancer patients. Blood J Am Soc Hematol. 2010;116(24):5377\u201382.","journal-title":"Blood J Am Soc Hematol"},{"issue":"12","key":"2198_CR65","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/onco.13540","volume":"25","author":"V Kumar","year":"2020","unstructured":"Kumar V, Shaw JR, Key NS, et al. D-dimer enhances risk\u2010targeted thromboprophylaxis in ambulatory patients with cancer. Oncologist. 2020;25(12):1075\u201383.","journal-title":"Oncologist"},{"issue":"1","key":"2198_CR66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/jth.14343","volume":"17","author":"IM Rietveld","year":"2019","unstructured":"Rietveld IM, Lijfering WM, le Cessie S, et al. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor. J Thromb Haemost. 2019;17(1):99\u2013109.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2198_CR67","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/jth.13205","volume":"14","author":"M P\u00e9pin","year":"2016","unstructured":"P\u00e9pin M, Kleinjan A, Hajage D, et al. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer. J Thromb Haemost. 2016;14(2):306\u201315.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2198_CR68","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/rth2.12197","volume":"3","author":"HL Obermeier","year":"2019","unstructured":"Obermeier HL, Riedl J, Ay C, et al. The role of ADAMTS-13 and von Willebrand factor in cancer patients: results from the Vienna cancer and thrombosis study. Res Pract Thromb Haemostasis. 2019;3(3):503\u201314.","journal-title":"Res Pract Thromb Haemostasis"},{"issue":"9","key":"2198_CR69","first-page":"2244","volume":"59","author":"L Oleksowicz","year":"1999","unstructured":"Oleksowicz L, Bhagwati N, DeLeon-Fernandez M. Deficient activity of von Willebrand\u2019s factor-cleaving protease in patients with disseminated malignancies. Cancer Res. 1999;59(9):2244\u201350.","journal-title":"Cancer Res"},{"issue":"4","key":"2198_CR70","first-page":"454","volume":"88","author":"PM Mannucci","year":"2003","unstructured":"Mannucci PM, Karimi M, Mosalaei A, Canciani MT, Peyvandi F. Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease). Haematologica. 2003;88(4):454\u201358.","journal-title":"Haematologica"},{"issue":"12","key":"2198_CR71","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1111\/j.1538-7836.2006.02273.x","volume":"4","author":"AY Nossent","year":"2006","unstructured":"Nossent AY, van Marion V, van Tilburg NH, et al. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis. J Thromb Haemost. 2006;4(12):2556\u201362.","journal-title":"J Thromb Haemost"},{"issue":"20","key":"2198_CR72","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1182\/blood-2014-08-595686","volume":"125","author":"AT Bauer","year":"2015","unstructured":"Bauer AT, Suckau J, Frank K, et al. von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans. Blood. 2015;125(20):3153\u201363. https:\/\/doi.org\/10.1182\/blood-2014-08-595686. [published Online First: Epub Date]|.","journal-title":"Blood"},{"issue":"1","key":"2198_CR73","first-page":"26","volume":"70","author":"J Shen","year":"1990","unstructured":"Shen J. Von Willebrand factor in acute leukemia. Zhonghua yi xue za zhi. 1990;70(1):26\u20138. 4.","journal-title":"Zhonghua yi xue za zhi"},{"issue":"5\u20136","key":"2198_CR74","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3109\/10428199809057608","volume":"31","author":"AB Federici","year":"1998","unstructured":"Federici AB, D\u2019amicob EA. The role of von Willebrand factor in the hemostatic defect of acute promyelocytic leukemia. Leuk Lymphoma. 1998;31(5\u20136):491\u201399.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2198_CR75","first-page":"1","volume":"41","author":"HM Abaza","year":"2016","unstructured":"Abaza HM, Farweez BA, Samaan SF. Platelet-dependent von Willebrand factor activity in acute myeloid leukemia patients: role in hemostatic alterations. Egypt J Haematol. 2016;41(1):1\u20138.","journal-title":"Egypt J Haematol"},{"issue":"06","key":"2198_CR76","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1160\/TH07-06-0419","volume":"99","author":"S Lethagen","year":"2008","unstructured":"Lethagen S, Hillarp A, Ekholm C, Mattson E, Halld\u00e9n C, Friberg B. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes. Thromb Haemost. 2008;99(06):1013\u201318.","journal-title":"Thromb Haemost"},{"key":"2198_CR77","doi-asserted-by":"publisher","first-page":"107602962514054","DOI":"10.1177\/10760296251405424","volume":"31","author":"M Abdulgayoom","year":"2025","unstructured":"Abdulgayoom M, Al-Asa\u2019d Y, Ali A, et al. High-Risk Bleeding in Acute Myeloid Leukemia: Clinical Presentation, Laboratory Markers, and Mortality Trends. Clinical and applied thrombosis\/hemostasis. official J Int Acad Clin Appl Thrombosis\/Hemostasis. 2025;31:10760296251405424. 10.1177\/10760296251405424[published Online First: Epub Date]|.","journal-title":"official J Int Acad Clin Appl Thrombosis\/Hemostasis"},{"issue":"6","key":"2198_CR78","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/annonc\/mdn755","volume":"20","author":"CY Chen","year":"2009","unstructured":"Chen CY, Tai CH, Tsay W, Chen PY, Tien HF. Prediction of fatal intracranial hemorrhage in patients with acute myeloid leukemia. Annals oncology: official J Eur Soc Med Oncol. 2009;20(6):1100\u20134. https:\/\/doi.org\/10.1093\/annonc\/mdn755. [published Online First: Epub Date]|.","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"issue":"11","key":"2198_CR79","first-page":"1530","volume":"91","author":"K Webert","year":"2006","unstructured":"Webert K, Cook RJ, Sigouin CS, Rebulla P, Heddle NM. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica. 2006;91(11):1530\u20137.","journal-title":"Haematologica"},{"issue":"1","key":"2198_CR80","first-page":"94","volume":"39","author":"M Franchini","year":"2013","unstructured":"Franchini M, Frattini F, Crestani S, Bonfanti C. Bleeding complications in patients with hematologic malignancies. Semin Thromb Hemost. 2013;39(1):94\u2013100. : 10.1055\/s-0032-1331154[published Online First: Epub Date]|.","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"2198_CR81","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1111\/jth.15074","volume":"18","author":"TF Wang","year":"2020","unstructured":"Wang TF, Makar RS, Antic D, et al. Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH. J Thromb haemostasis: JTH. 2020;18(12):3174\u201383. https:\/\/doi.org\/10.1111\/jth.15074. [published Online First: Epub Date]|.","journal-title":"J Thromb haemostasis: JTH"},{"issue":"11","key":"2198_CR82","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1007\/s00277-023-05466-1","volume":"102","author":"K Mishra","year":"2023","unstructured":"Mishra K, Jandial A, Sandal R, et al. Bleeding risk assessment in immune thrombocytopenia. Ann Hematol. 2023;102(11):3007\u201314. https:\/\/doi.org\/10.1007\/s00277-023-05466-1. [published Online First: Epub Date]|.","journal-title":"Ann Hematol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02198-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02198-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02198-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:03:27Z","timestamp":1784642607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02198-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2198"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02198-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research adhered to the Code of Ethics of the World Medical Association (Declaration of Helsinki) for studies involving human subjects. The project was approved by Mansoura University board of ethics with code R.24.10.2858. All the cases involved in the study provided the written consent for participation and publication of scientific data.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain information or images that could lead to identification of a study participant.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"276"}}